Involvement of glutamate NMDA and AMPA receptors, glial cells and IL-1β in the spinal hyperalgesia evoked by the chemokine CCL2 in mice

Neuroscience Letters

Volumn 502, Issue 3, 2011, Pages 178-181

  Baamonde, Ana ^a   Hidalgo, Agustín ^a   Menéndez, Luis ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

AMPA; Astroglia; CCL2; IL 1 ; Microglia; NMDA; Spinal cord; Thermal hyperalgesia

Indexed keywords

AMINOADIPATE SEMIALDEHYDE DEHYDROGENASE; AMPA RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CYTOKINE; EXCITATORY AMINO ACID RECEPTOR; INTERLEUKIN 1BETA; MINOCYCLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; ELECTROPHYSIOLOGY; GLIA CELL; HYPERALGESIA; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; HYPERALGESIA; INTERLEUKIN-1BETA; MALE; MICE; NEUROGLIA; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD;

EID: 80052393112     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.07.038     Document Type: Article

References (29)

1. Abbadie C., Bhangoo S., De Koninck Y., Malcangio M., Melik-Parsadaniantz S., White F.A. Chemokines and pain mechanisms. Brain Res. Rev. 2009, 60:125-134.
2. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., MacIntyre D.E., Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7947-7952.
3. Beirith A., Santos A.R., Calixto J.B. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Res. 2002, 924:219-228.
4. Dansereau M.A., D: Gosselin R., Pohl M., Pommier B., Mechighel P., Mauborgne A., Rostene W., Kitabgi P., Beaudet N., Sarret P., Melik-Parsadaniantz S. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J. Neurochem. 2008, 106:757-769.
5. Gao Y.J., Ji R.R. Chemokines neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol. Ther. 2010, 126:56-68.
6. Gao Y.J., Zhang L., Samad O.A., Suter M.R., Yasuhiko K., Xu Z.Z., Park J.Y., Lind A.L., Ma Q., Ji R.R. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J. Neurosci. 2009, 29:4096-4108.
7. Jeon S.M., Lee K.M., Cho H.J. Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain. Brain Res. 2009, 1251:103-111.
8. Jung H., Bhangoo S., Banisadr G., Freitag C., Ren D., White F.A., Miller R.J. Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. J. Neurosci. 2009, 29:8051-8062.
9. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 2008, 28:5189-5194.
10. Khasabova I.A., Stucky C.L., Harding-Rose C., Eikmeier L., Beitz A.J., Coicou L.G., Hanson A.E., Simone D.A., Seybold V.S. Chemical interactions between fibrosarcoma cancer cells and sensory neurons contribute to cancer pain. J. Neurosci. 2007, 27:10289-10298.
11. Knerlich-Lukoschus F., Juraschek M., Blomer U., Lucius R., Mehdorn H.M., Held-Feindt J. Force-dependent development of neuropathic central pain and time-related CCL2/CCR2 expression after graded spinal cord contusion injuries of the rat. J. Neurotrauma 2008, 25:427-448.
12. Komatsu T., Sakurada S., Kohno K., Shiohira H., Katsuyama S., Sakurada C., Tsuzuki M., Sakurada T. Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide. Biochem. Pharmacol. 2009, 78:1026-1034.
13. Kurihara T., Bravo R. Cloning and functional expression of mCCR2 a murine receptor for the C-C chemokines JE and FIC. J. Biol. Chem. 1996, 271:11603-11607.
14. Liao Y.H., Zhang G.H., Jia D., Wang P., Qian N.S., He F., Zeng X.T., He Y., Yang Y.L., Cao D.Y., Zhang Y., Wang D.S., Tao K.S., Gao C.J., Dou K.F. Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes. Brain Res. 2011, 1368:324-335.
15. Menendez L., Lastra A., Hidalgo A., Baamonde A. Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice. J. Neurosci. Methods 2002, 113:91-97.
16. Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., Miller R.J. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 2001, 21:5027-5035.
17. Quinones M.P., Kalkonde Y., Estrada C.A., Jimenez F., Ramirez R., Mahimainathan L., Mummidi S., Choudhury G.G., Martinez H., Adams L., Mack M., Reddick R.L., Maffi S., Haralambous S., Probert L., Ahuja S.K., Ahuja S.S. Role of astrocytes and chemokine systems in acute TNFalpha induced demyelinating syndrome. CCR2-dependent signals promote astrocyte activation and survival via NF-kappaB and Akt. Mol. Cell. Neurosci. 2008, 37:96-109.
18. Ren K. Emerging role of astroglia in pain hypersensitivity. Jpn. Dent. Sci. Rev. 2010, 46:86.
19. Schreiber K.L., Beitz A.J., Wilcox G.L. Activation of spinal microglia in a murine model of peripheral inflammation-induced long-lasting contralateral allodynia. Neurosci. Lett. 2008, 440:63-67.
20. Semple B.D., Frugier T., Morganti-Kossmann M.C. CCL2 modulates cytokine production in cultured mouse astrocytes. J. Neuroinflammation 2010, 7:67.
21. Serrano A., Paré M., McIntosh F., Elmes S.J., Martino G., Jomphe C., Lessard E., Lembo P.M., Vaillancourt F., Perkins M.N., Cao C.Q. Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain. Mol. Pain 2010, 6:90.
22. Stock C., Schilling T., Schwab A., Eder C. Lysophosphatidylcholine stimulates IL-1beta release from microglia via a P2X7 receptor-independent mechanism. J. Immunol. 2006, 177:8560-8568.
23. Tanaka T., Minami M., Nakagawa T., Satoh M. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci. Res. 2004, 48:463-469.
24. Thacker M.A., Clark A.K., Bishop T., Grist J., Yip P.K., Moon L.D., Thompson S.W., Marchand F., McMahon S.B. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur. J. Pain 2009, 13:263-272.
25. Wang X.M., Hamza M., Wu T.X., Dionne R.A. Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation correlation to clinical pain. Pain 2009, 142:275-283.
26. Watkins L.R., Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discov. 2003, 2:973-985.
27. Weyerbacher A.R., Xu Q., Tamasdan C., Shin S.J., Inturrisi C.E. N-methyl-d-aspartate receptor (NMDAR) independent maintenance of inflammatory pain. Pain 2010, 148:237-246.
28. Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De Koninck Y., Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J. Neurosci. 2007, 27:12396-12406.
29. Zhang R.X., Li A., Liu B., Wang L., Ren K., Zhang H., Berman B.M., Lao L. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 2008, 135:232-239.